Patents by Inventor Earl E. C. Fager

Earl E. C. Fager has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4338308
    Abstract: 4-N-Lysyl-2'-N-des-.beta.-lysyl antibiotic AX-127B-1 and the pharmaceutically acceptable salts thereof. The compounds are useful as intermediates in the preparation of 3-O-demethyl 4-N-lysyl-2'-N-des-.beta.-lysyl antibiotic AX-127B-1 and as a broad spectrum antibacterial agents.
    Type: Grant
    Filed: November 10, 1980
    Date of Patent: July 6, 1982
    Assignee: Abbott Laboratories
    Inventors: Paul Kurath, Earl E. C. Fager
  • Patent number: 4219642
    Abstract: A new fortimicin, fortimicin AO. The compound is coproduced in the fermentation of Micromonospora olivoasterospora ATCC No. 21819, 31009 or 31010 along with fortimicin A, Isofortimicin, Fortimicin E and a number of other minor factors. The compound is useful as an intermediate in synthesizing fortimicin A0 derivatives which are useful as antibiotics.
    Type: Grant
    Filed: March 29, 1979
    Date of Patent: August 26, 1980
    Assignee: Abbott Laboratories
    Inventors: Paulette Collum, Earl E. C. Fager
  • Patent number: 4219644
    Abstract: New fortimicins, fortimicins AH and AI. The compounds are coproduced in the fermentation of Micromonospora olivoasterospora ATCC No. 21819, 31009 or 31010 along with fortimicin A, Isofortimicin, Fortimicin E and a number of other minor factors. The compounds are useful as an intermediate in synthesizing fortimicins AH and AI derivatives which are useful as antibiotics.
    Type: Grant
    Filed: March 29, 1979
    Date of Patent: August 26, 1980
    Assignee: Abbott Laboratories
    Inventors: Alma W. Goldstein, Earl E. C. Fager
  • Patent number: 4214078
    Abstract: A new fortimicin, fortimicin AL. The compound is coproduced in the fermentation of Micromonospora olivoasterospora ATCC No. 21819, 31009 or 31010 along with fortimicin A, Isofortimicin, Fortimicin E and a number of other minor factors. The compound is useful as an intermediate in synthesizing fortimicin AL derivatives which are useful as antibiotics.
    Type: Grant
    Filed: March 29, 1979
    Date of Patent: July 22, 1980
    Assignee: Abbott Laboratories
    Inventors: Alma W. Goldstein, Earl E. C. Fager